BMO Capital Maintains Outperform on BrightSpring Health, Raises Price Target to $84

Benzinga · 1d ago
BMO Capital analyst Sean Dodge maintains BrightSpring Health (NASDAQ:BTSG) with a Outperform and raises the price target from $80 to $84.